glp-1 therapies success rates Receptor Agonist Market Growth Analysis GLP-1 Drug Market: the rapid
Description
New research suggests that they may also support other areas of health, i ncluding reducing inflammation, promoting cellular health, and even improving kidney, liver and brain health
Results : Both medications were associated with an increased risk of vestibular disorders
doi: 10.1016/j.gie.2024.12.019
Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet
Whats changing: First GLP-1 weight loss pill approved: Novo Nordisks oral Wegovy is expected to be widely available, with another pill from Eli Lilly likely later this year offering a needle-free option many patients prefer
